Adrabetadex Uses, Dosage, Side Effects and more
Adrabetadex is under investigation in clinical trial NCT03887533 (Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1).
Trade Name | Adrabetadex |
Generic | Adrabetadex |
Adrabetadex Other Names | Adrabetadex |
Type | |
Formula | C54H94O38 |
Weight | Average: 1351.308 Monoisotopic: 1350.542308587 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | January 7, 2025 at 1:49 am |